Literature DB >> 2048376

Assessment of psychiatric and psychosocial factors disposing to chronic outcome of dermatoses.

A Laihinen.   

Abstract

In many skin diseases, itching and scratching is a vicious circle, which prolongs the disease. The aim of this study was to investigate the mechanisms which make itching skin diseases more chronic. The patients consisted of seven diagnostic groups--79 inpatients all together. The dermatoses were: dermatitis herpetiformis, lichen ruber planus, chronic eczema, atopic eczema, neurodermatitis circumscriptus, prurico psychogenous and lichen obtusus corneus. Both psychiatric and dermatological examinations were performed. Psychiatric disturbance was clearly greater than in the average population. The chronifying mechanisms were the following: personality disorder as a treatment problem; emotional infantility, which makes the illness itself an important security factor; itching and scratching as pleasure and content of life; the accumulation of various other diseases, both somatic and psychiatric; and untreated depression. Information was obtained on the possibilities of psychiatric treatment and psychosocial rehabilitation.

Entities:  

Mesh:

Year:  1991        PMID: 2048376

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  3 in total

1.  Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK).

Authors:  Marianne Klokk; Karl Gunnar Gotestam; Arnstein Mykletun
Journal:  BMC Dermatol       Date:  2010-04-22

2.  Psychiatric Comorbidities in Non-psychogenic Chronic Itch, a US-based Study.

Authors:  Rachel Shireen Golpanian; Zoe Lipman; Kayla Fourzali; Emilie Fowler; Leigh A Nattkemper; Yiong Huak Chan; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2020-06-11       Impact factor: 3.875

3.  Assessment of the anxiety and depression among patients with idiopathic pruritus ani.

Authors:  Karolina Hadasik; Hubert Arasiewicz; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.